StockData
Biotricity Inc. logo

Biotricity Inc. (BTCY) stock

BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$0.05+0.00 (+8.70%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Biotricity statistics

40 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
6.70%
3.32%
Shares Change (QoQ)
-29.8%
0.20%
Float
20M
37M
Shares Held by Insiders
0.00%
10.5%
Shares Held by Institutions
0.24%
60.5%

MarginsIndustry

Gross Margin
81.5%
55.9%
Operating Margin
9.56%
-5.12%
Pretax Margin
-16.4%
-2.32%
Profit Margin
-16.4%
-9.29%
EBITDA Margin
9.56%
-2.52%

Returns on capitalIndustry

Return on Assets (ROA)
-44.6%
-12.3%

Financial positionIndustry

Current Ratio
0.15
2.49
Quick Ratio
0.08
1.53
Interest Coverage
0.47
-1.63

GrowthIndustry

Revenue Growth (YoY)
13.4%
9.42%
Revenue Growth (3Y CAGR)
18.4%
7.08%
Revenue Growth (5Y CAGR)
36.4%
11.8%

EfficiencyIndustry

Asset Turnover
2.72
0.59
Inventory Turnover
1.89
2.20
Revenue Per Employee
$356.55K
$331.99K
Profits Per Employee
-$58.51K
-$46.47K
Employee Count
46
193

Income statement (TTM)Industry

Revenue
$16.40M
$108.17M
Gross Profit
$13.36M
$62.29M
Operating Income
$1.57M
-$3.72M
Pretax Income
-$2.69M
-$1.83M
Net Income
-$2.69M
-$6.19M
EBITDA
$1.57M
-$1.98M
EPS (Diluted)
-$0.14
-$0.11

Balance sheetIndustry

Net Cash (Debt)
$466.50K
$3.95M
Net Cash Per Share
$0.02
$0.26
Equity (Book Value)
-$35.41M
$63.80M
Book Value Per Share
-$1.78
$3.26
Tangible Book Value
-$35.41M
$11.61M
Working Capital
-$31.75M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
$161.66K
-$483.87K

Taxes and interestIndustry

Interest Expense
$3.36M
$5.40M

Scores and fair valueIndustry

Piotroski F-Score
5
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodBTCYS&P 500DifferenceBTCY per yearS&P 500 per year
1 month-40.9%+0.6%−41.5 pts
3 months-55.7%+3.4%−59.0 pts
Year to date-83.3%+13.3%−96.6 pts
1 year-92.2%+16.6%−108.8 pts
3 years-97.7%+86.4%−184.1 pts-71.5%+23.1%
5 years-99.7%+81.9%−181.6 pts-69.4%+12.7%
10 years-99.7%+318.9%−418.6 pts-44.3%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M BTCY shares were sold short on Oct 30, 2026, down 0.3% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 46.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026118,661-0.3%163,6361.0
Oct 15, 2026119,069+0.6%133,4891.0
Sep 30, 2026118,387-5.7%132,2521.0
Sep 15, 2026125,605+1.7%22,1415.7
Aug 31, 2026123,525+0.7%13,6459.1
Aug 14, 2026122,721-1.3%32,2823.8
Jul 31, 2026124,283+6.0%24,4505.1
Jul 15, 2026117,236-0.4%83,4211.4
Jun 30, 2026117,714+1.3%81,4661.4
Jun 15, 2026116,197+0.2%37,5283.1
May 29, 2026115,975-8.2%505,5701.0
May 15, 2026126,366+1.0%149,8251.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?